Pharmalucence formally CIS-US Inc.
Careers News Resources Contact  
    Company
 
  Manufacturing Capabilities
 
  Facility Details 
 
  Nuclear Medicine Products
 
 
 





Company News
Come See Us
Pharmalucence
Company News



August 16, 2012

Pharmalucence receives FDA approval for use of Sulfur Colloid Injection (SCI) to locate lymph nodes in malignant melanoma patients.

Pharmalucence receives FDA approval for use of Sulfur Colloid Injection (SCI) to locate lymph nodes in malignant melanoma patients.

PDF 





For more information, please contact:
John Felock
Director; Sales, Marketing and Customer Service
1-781-687-1245
jfelock@pharmalucence.com



29 Dunham Road, Billerica, MA 01821 | Telephone: 781-275-7120    © Pharmalucence Inc. All rights reserved.
HOME   |   SITE MAP   |   LEGAL STATEMENT   |   PRIVACY POLICY   |